Abstract: An additive manufacturing (AM) system comprising a process distortion compensation computing system configured to determine a digital nominal model that represents a physical target object excluding a distortion, and a digital distortion model that represents the physical target object including at least one distortion. The AM system further comprises an AM peripheral device configured to form a three-dimensional physical object based on a digital compensation model. The process distortion compensation computing system determines a material volume difference between the digital nominal model and the digital distortion model, and generates the digital compensation model that compensates for the material volume difference.

Abstract: An additive manufacturing (AM) system includes a process distortion compensation computing system and an AM peripheral device. The process distortion compensation computing system determines a digital nominal model that represents a physical target object excluding a distortion, and a digital distortion model that represents the physical target object including at least one distortion. The AM peripheral device forms a three-dimensional (3D) physical object based on a digital compensation model. The process distortion compensation computing system also determines a digital skeletal model indicating a predicted change in at least one of the shape and volume of the nominal model, and generates the digital compensation model based on the skeletal model that compensates for the at least one distortion.

Abstract: Systems and methods for displaying and associating context images with zones or devices of a security system or a home automation system are provided. Such systems and methods may include associating each of a plurality of zones or devices of the security system or the home automation system with a respective context image and displaying the respective context image for one of the plurality of zones or devices in response to a user interface of the security system or the home automation system receiving user input.

Abstract: The present invention provides a 2,4,6-trisubstituted s-triazine compound represented by general formula (I) or pharmaceutically acceptable salts, prodrugs or solvates thereof, a preparation method therefor, and use of these compounds in preparing drugs for preventing or treating diseases associated with protein kinase and vimentin dysregulation, and cell vacuolization, and in particular, drugs for treating or preventing cancer growth and metastasis, tissue fibrosis and atherosclerosis.

Abstract: An additive manufacturing (AM) system comprising a process distortion compensation computing system configured to determine a digital nominal model that represents a physical target object excluding a distortion, and a digital distortion model that represents the physical target object including at least one distortion. The AM system further comprises an AM peripheral device configured to form a three-dimensional physical object based on a digital compensation model. The process distortion compensation computing system determines a material volume difference between the digital nominal model and the digital distortion model, and generates the digital compensation model that compensates for the material volume difference.

Abstract: This invention disclosed a method for preparing the ultrafine intermetallic particles reinforced metal matrix composites (MMC). The particle size of ultrafine intermetallic particles is about 0.01˜5 ?m. In this method, intermetallic particles and metal matrix were first ball milled together to get the mixed powder. Then, powders were cold-pressed then vacuum melting with metals to prepare the reinforced metal matrix composites materials. The intermetallic particles addition amount in this is 1˜30 wt %. This invention improve the dispersion properties of intermetallic particles while increase the particle/matrix interface strength. The ultrafine intermetallic particles reinforced MMC shows the very good performance with good ductility and strength.

Abstract: This invention disclosed a method for preparing the ultrafine intermetallic particles reinforced metal matrix composites (MMC). The particle size of ultrafine intermetallic particles is about 0.01˜5 ?m. In this method, intermetallic particles and metal matrix were first ball milled together to get the mixed powder. Then, powders were cold-pressed then vacuum melting with metals to prepare the reinforced metal matrix composites materials. The intermetallic particles addition amount in this is 1˜30 wt %. This invention improve the dispersion properties of intermetallic particles while increase the particle/matrix interface strength. The ultrafine intermetallic particles reinforced MMC shows the very good performance with good ductility and strength.

Abstract: A method of titering adeno-associated virus particles in a sample, said method comprising the steps of contacting target cells with a DNA synthesis inhibitor and an agent that increases the activity of the CMV immediate early promoter; contacting target cells treated as in step (a) with a sample containing adeno-associated virus particles; and determining the number of target cells infected by said adeno-associated virus particles in said sample, wherein said number of target cells infected is directly proportional to the titer of said particles in said sample, thereby determining the titer if said adeno-associated virus particles.

Abstract: Compositions and methods are provided for modulating the expression of bcl-x. Antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding bcl-x are preferred. Methods of using these compounds for modulation of bcl-x expression and for treatment of diseases associated with expression of bcl-x are also provided. Methods of sensitizing cells to apoptotic stimuli are also provided.

Abstract: Compositions and methods are provided for modulating the expression of bcl-x. Antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding bcl-x are preferred. Methods of using these compounds for modulation of bcl-x expression and for treatment of diseases associated with expression of bcl-x are also provided.